InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
6
T+90 hit rate
0%
T+90 mean return
-20.5%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Deignan Charles A., Chief Financial Officer. Officer active across 1 company, notably Clearside Biomedical, Inc.. Aggregated, 12 filings have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €87k. Activity tracked since 21 June 2021. The latest transaction was disclosed on 19 January 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
12,900 shares@ US$1.2814.0% of flowCommon StockSEC:0001209191-24-001959:0
34,090 shares@ US$0.4011.7% of flowCommon StockSEC:0001209191-23-049346:0
14,030 shares@ US$1.5018.0% of flowCommon StockSEC:0001209191-23-004258:0
23,636 shares@ US$0.408.2% of flowCommon StockSEC:0001209191-22-062169:0
46,250 shares0Common StockSEC:0001209191-22-005437:0
46,250 shares0Common StockSEC:0001209191-22-005437
43,750 shares0Common StockSEC:0001209191-22-004194
43,750 shares0Common StockSEC:0001209191-22-004194:0
2,800 shares@ US$6.410.021% mcap29.3% of flowCommon StockSEC:0001209191-21-057457:0
2,800 shares@ US$6.4114.1% of flowCommon StockSEC:0001209191-21-057457
2,938 shares@ US$4.379.9% of flowCommon StockSEC:0001209191-21-042803
2,938 shares@ US$4.370.015% mcap20.7% of flowCommon StockSEC:0001209191-21-042803:0
12 of 12 declarations
About Deignan Charles A.
Charles A. Deignan is the Chief Financial Officer of Clearside Biomedical, Inc. In this role, he is responsible for financial management and strategy for the company. Clearside Biomedical, Inc. is committed to developing treatments for eye diseases. Charles plays a key role in financial planning and analysis.
